No Result
View All Result
Saturday, March 6, 2021
Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish
Near future
  • Home
  • Tech
  • Medicine
  • Society
  • Environment
  • Spazio
  • Transportation
  • Weather
  • concepts
  • H+
Near future
No Result
View All Result

OncoHost, artificial intelligence that can “design” oncological therapies

The use of artificial intelligence to evaluate and refine cancer therapies can revolutionize the fight against cancer. Here are the researches of OncoHost.

Gianluca Riccio di Gianluca Riccio
January 20 2021
in Medicine
OncoHost, artificial intelligence that can “design” oncological therapies
Send to FacebookPin on PinterestSend on TwitterSend on Whatsappon Linkedin

OncoHost develops AI technology to characterize, analyze and predict the response of cancer patients to treatments. And he just raised $ 8 million in funds. A nice figure.

OncoHost will use it to fund clinical trials and prepare for launch. Its AI platform for profiling patient response to cancer therapies promises to be revolutionary.

OncoHost, brilliant challenge to a diabolical enemy

World data says The death rate for cancer it is not increasing, but the incidence is.

Maybe you are also interested

Hour One, the AI ​​that creates our talking and realistic digital clone.

Here's how AI can target our weaknesses to influence us

Machine learning now generates realistic genomes of people who don't exist

AI and Mental Health: Can Technology Digitize Psychologists?

According to a recent study, people born after 1960 will have at least a one in two chance of contracting cancer in their lifetime.

Some cancers, such as breast cancer, have a five-year relative survival rate of nearly 100%. This is not the case for everyone, however. Other cancers are difficult to treat and have high recurrence rates. Glioblastoma and ovarian cancer recur in almost all patients. And they do it independently of cancer therapies.

Oncological therapies, decisive for better or for worse

OncoHost, artificial intelligence to improve oncological therapies
Yuval Shaked, in the center. Behind him, the OncoHost team.

OncoHost, as mentioned, is a precision clinical oncology company. Yuval Shaked, who co-founded the company in 2017, he is a member of the cell biology and cancer research department of the Israeli Technion Institute of Technology.

His research confirms that oncological therapies induce a series of undesirable effects in healthy tissues. Some may even promote tumor aggression.

Cancer therapies (including immunotherapy, chemotherapy, targeted medications, radiation, and surgery) can trigger a variety of physiological reactions in patients, Shaked says. These effects include elevated levels of cytokines, a large and loose category of small proteins important in cell signaling. Not only that: also growth factors, enzymes and chemokines (a sub-category of cytokines) in the blood.

How does OncoHost work?

OncoHost technology aims to identify and characterize responses to oncological therapies. It aims to discover new goals to improve the fight against cancer through artificial intelligence.

Applying AI to predict response to cancer therapies is not a new idea. A recent study published in Clinical Cancer Research found that an algorithm trained on standard CT scans could anticipate tumor response in lung cancer patients. In June, a research team in France launched a new study to monitor cancer patients. As? Using an artificial intelligence system.

OncoHost takes a different approach. Uniquely analyzes changes in blood to monitor the dynamics of biological processes in response to cancer therapies, and to identify potential drug targets.

The company's lab uses protein analysis technology to determine the levels of thousands of proteins associated with resistance to therapy and tumor spread in a single plasma sample.

For this, OncoHost claims to be able to monitor a patient's response to cancer therapies in real time.

Cancer therapies of the future: the next developments

OncoHost has established a preclinical program to test the efficacy of new drug combinations in tumor models in mice. Soon, the company will launch a clinical trial for glioblastoma patients undergoing standard-of-care therapy.

Proteomic analysis could lead to great advances in the development of more effective cancer therapies.

The future of personalized cancer care is no longer a distant reality. It is within our reach.

tags: AIcancerartificial intelligence
Previous post

Fast battery charging at 100%, Storedot has one that takes 5 minutes

Next article

Covid variants: can they bypass vaccines? The first answers arrive

Gianluca Riccio

Gianluca Riccio

Gianluca Riccio, born in 1975, is the creative director of an advertising agency, copywriter and journalist. He is affiliated with Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists. Since 2006 he directs Futuroprossimo.it, the Italian resource of Futurology.

Maybe you are also interested in:

An AI reads the brain and creates an attractive face based on personal taste
Medicine

An AI reads the brain and creates an attractive face based on personal taste

covid africa
Medicine

2-4 million direct and indirect deaths from Covid not counted in Africa

plant against dizziness
Medicine

An implant in the inner ear restores balance to those suffering from vertigo

Next article
Covid variants

Covid variants: can they bypass vaccines? The first answers arrive

Micromobility, Robotaxi, Smart City: 3 predictions for 2021

Micromobility, Robotaxi, Smart City: 3 predictions for 2021

Leave a comment Cancel reply

Your email address will not be published.

Collaborate!

We are open to visions about the future. Submit an article, disclose the results of a search or scientific discoveries, shows points of view on a theme, tells about a change.

Contact us
The last
  • An AI reads the brain and creates an attractive face based on personal tasteMarch 6 2021
    An artificial intelligence is trained to read brain signals and produce the image of an attractive face for everyone.
  • Triton 13000/2 Titanic Explorer, the submarine that flies underwaterMarch 6 2021
    A small "bubble" submarine with retractable gull wings is able to "fly" at will under water, from bottom to surface, offering maneuverability and spectacular footage of the depths.
  • Scientists have discovered a mysterious layer in the Earth's coreMarch 5 2021
    A new layer inside the Earth's core shows us new scenarios on its formation and on the geological phenomena taking place before man arrived.

Most read of the week

  • M1, the huge 165-inch MicroLED TV vanishes into thin air when turned off

    M1, the huge 165-inch MicroLED TV vanishes into thin air when turned off

    68 shares
    Share 27 Tweet 17
  • Scientists levitate a plastic disc using only light

    66 shares
    Share 26 Tweet 16
  • World population growth will stop after centuries

    3135 shares
    Share 1254 Tweet 784
  • V90 Villa Edition, camper with terrace on the second floor

    229 shares
    Share 91 Tweet 57

Futuroprossimo.it is an Italian resource of futurology opened since 2006: every day news about the near future. Scientific discoveries, medical research, prototypes, concepts and predictions about the future for free.

Tag

Environment Architecture Communication concepts Advice Energy Events Gadgets The future of yesterday The newspaper of tomorrow Medicine Military Weather Robotica Society Spazio Technology transhumanism Transportation Video

Categories

The author

Gianluca Riccio, copywriter and journalist - Born in 1975, he is the creative director of an advertising agency, he is affiliated with the Italian Institute for the Future, World Future Society and H +, Network of Italian Transhumanists.

Collaborate! Are you interested in writing a post on Futuroprossimo? Click here for contacts.

Home / Author / IDEA / archive / Promo on FP

© 2020 Futuroprossimo - Tailored by Be Here

© 2020 Futuroprossimo - Tailored by Be Here

  • Home
  • Contact
  • archive
  • Technology
  • Medicine
  • Transportation
  • Weather
  • Society
  • Environment
  • transhumanism

© 2019 Futuroprossimo - Tailored by To be here

This site uses cookies. By continuing to read it, you consent to their use.